58Â° Congresso Nazionale SCIVAC: Oncologia veterinaria

More documents

Recommendations

Info

58° Congresso Nazionale SCIVAC • Milano, 7-9 Marzo 2008 • Oncologia veterinaria - Alle soglie del III Millennio Week 1 - Vincristine (0.5-0.7 mg/m 2 IV), Asparaginase (400 IU/kg SC), Prednisone (2 mg/kg PO SID); Week 2 - Cyclophosphamide (250 mg/m 2 IV), Prednisone 1.5 mg/kg PO SID; Week 3 - Vincristine, prednisone (1.0 mg/kg PO SID); Week 4 - Doxorubicin (30 mg/m 2 IV), Prednisone (0.5 mg/kg PO SID); Week 6 - Vincristine; Week 7 - Cyclophosphamide; Week 8 - Vincristine; Week 9 - Doxorubicin. If in complete remission at week 9, this cycle is continued at 2-week intervals until week 19, at which time therapy is discontinued. The COPLA - LVP Protocol is a concurrent combination that is notable for low side effect rate and high induction of remission, although overall survival times are not as long as with the University of Wisconsin approach. COPLA protocol: • Cyclophosphamide 50 mg/m 2 , PO, eod for 56 days (8 weeks); • Vincristine (Oncovin) 0.5-0.7 mg/m 2 , IV, starting day 1, q 7 days for 77 days (11 weeks), omitting weeks 6 and 9; • Prednisone 20 mg/m 2 , PO, sid for 7 days; then 20 mg/m 2 , PO, eod until relapse or adverse steroid effects, in which case taper dose and discontinue; • L-asparaginase 10,000 IU/m 2 , SC on days 1 and 8; • Doxorubicin (Adriamycin) 30 mg/m 2 , IV, on weeks 6, 9 and 12. CBC’s and lymph node/mass measurements should be obtained weekly, in order to modify treatment if deemed necessary. MAINTENANCE LVP protocol • (Chlorambucil) Leukeran 4 mg/m 2 , PO, eod; • Vincristine 0.5-0.7 mg/m 2 , IV, q 14 days for 2 doses, q 21 days for 3 doses, q 28 days thereafter; • Prednisone 20 mg/m 2 , PO, sid for 7 days; then 20 mg/m 2 , PO, eod until relapse or adverse steroid effects in which case taper dose and discontinue. Address for correspondence: Barbara E. Kitchell Professor and Director, Center for Comparative Oncology Michigan State University College of Veterinary Medicine 88
58° Congresso Nazionale SCIVAC • Milano, 7-9 Marzo 2008 • Oncologia veterinaria - Alle soglie del III Millennio Barbara E. Kitchell DVM, PhD, Dipl ACVIM, Michigan, USA Treatment for bladder tumors Domenica, 9 Marzo 2008, ore 12.20 89
Page 1:
58° Congresso Nazionale SCIVAC •
Page 5 and 6:
Page 9:
Page 12 and 13:
Page 14 and 15:
nr. 6312 Sedazione IL PASSATO È FI
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39: 58° Congresso Nazionale SCIVAC •
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 165 and 166:
POSTER Gli estratti sono elencati i
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
show all

58Â° Congresso Nazionale SCIVAC: Oncologia veterinaria

Create successful ePaper yourself

Delete template?

Save as template?